|
Market Closed -
Sao Paulo
16:06:00 2026-08-21 EDT
|
5-day change | 1st Jan Change | ||
| 36.23 BRL | +31.60% |
|
+19.93% | +10.39% |
| 11:12am | European Equities Traded in the US as American Depositary Receipts Track Higher in Friday Trading | MT |
| 04:16am | BioNTech, neoantigens by proxy |  |
Evolution of the Average Target: BioNTech SE
Evolution of the Target Price: BioNTech SE
Changes in Analyst Recommendations: BioNTech SE
| Consensus | Analysts' recommendations evolution (4 months) | Financial estimates divergence | Analysts' Target price divergence | Objective/dr gap | ||
|---|---|---|---|---|---|---|
 | +8.72% | |||||
| +5.57% | |||||
| +59.93% | |||||
| +9.58% | |||||
| -4.3% | |||||
| +12.59% | |||||
| -4.57% | |||||
| +14.93% | |||||
| -1.29% | |||||
| Average | +11.24% | |||||
| Weighted average by Cap. | +11.12% |
Analysts' Consensus
Analyst Consensus Detail
Consensus revision (last 18 months)
Analysts covering the company
| JEFFERIES | Akash Tewari |
| Berenberg Bank | |
| alphavalue | Anas Patel |
| BERNSTEIN RESEARCH | |
| BERENBERG | Harry Gillis |
| Morgan Stanley | |
| UBS | |
| Bernstein | |
| GOLDMAN SACHS | Asad Haider |
| DEUTSCHE BANK RESEARCH | Emmanuel Papadakis |
| Leerink Partners | |
| JPMorgan Chase | |
| BofA Securities | |
| Truist Securities | |
| Citigroup | |
| JPMORGAN | Jessica Fye |
| Wells Fargo Securities | |
| Evercore ISI | |
| Jefferies & Co. | |
| HC Wainwright | |
| TD Cowen | |
| BMO Capital | |
| Canaccord Genuity | |
| Oppenheimer | |
| HSBC | |
| Deutsche Bank Securities | |
| Redburn | |
| SVB Securities LLC | |
| Kempen | |
| DEUTSCHE BANK | Emmanuel Papadakis |
| SVB Leerink | |
| BRYAN GARNIER | Olga Smolentseva |
| Bryan, Garnier & Co. | |
| Wolfe Research | |
| J.P. Morgan Chase |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- BNTX Stock
- B1NT34 Stock
- Consensus BioNTech SE
Select your edition
All financial news and data tailored to specific country editions
